These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19626426)

  • 1. Arsonoliposomes for the potential treatment of medulloblastoma.
    Favretto ME; Marouf S; Ioannou P; Antimisiaris SG; Parker TL; Kallinteri P
    Pharm Res; 2009 Oct; 26(10):2237-46. PubMed ID: 19626426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsonoliposomes: effect of arsonolipid acyl chain length and vesicle composition on their toxicity towards cancer and normal cells in culture.
    Gortzi O; Antimisiaris SG; Klepetsanis P; Papadimitriou E; Ioannou PV
    Eur J Pharm Sci; 2003 Feb; 18(2):175-83. PubMed ID: 12594011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the lipid membrane composition of arsonoliposomes affect their anticancer activity? A cell culture study.
    Zagana P; Haikou M; Giannopoulou E; Ioannou PV; Antimisiaris SG
    Mol Nutr Food Res; 2009 May; 53(5):592-9. PubMed ID: 18727012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsonoliposomes, a novel class of arsenic-containing liposomes: effect of palmitoyl-arsonolipid-containing liposomes on the viability of cancer and normal cells in culture.
    Gortzi O; Papadimitriou E; Kontoyannis CG; Antimisiaris SG; Ioannou PV
    Pharm Res; 2002 Jan; 19(1):79-86. PubMed ID: 11837704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsonoliposomes: novel nanosized arsenic-containing vesicles for drug delivery.
    Fatouros DG; Ioannou PV; Antimisiaris SG
    J Nanosci Nanotechnol; 2006; 6(9-10):2618-37. PubMed ID: 17048471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsonoliposome interaction with thiols: effect of pegylation and arsonolipid content of arsonoliposomes on their integrity during incubation in glutathione.
    Haikou MN; Zagana P; Ioannou PV; Antimisiaris SG
    J Nanosci Nanotechnol; 2006; 6(9-10):2974-8. PubMed ID: 17048506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro antileishmanial and trypanocidal activities of arsonoliposomes and preliminary in-vivo distribution in BALB/c mice.
    Antimisiaris SG; Ioannou PV; Loiseau PM
    J Pharm Pharmacol; 2003 May; 55(5):647-52. PubMed ID: 12831507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsonoliposomes: effect of lipid composition on their stability and morphology.
    Piperoudi S; Ioannou PV; Frederik P; Antimisiaris SG
    J Liposome Res; 2005; 15(3-4):187-97. PubMed ID: 16393910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo distribution of arsonoliposomes: effect of vesicle lipid composition.
    Zagana P; Haikou M; Klepetsanis P; Giannopoulou E; Ioannou PV; Antimisiaris SG
    Int J Pharm; 2008 Jan; 347(1-2):86-92. PubMed ID: 17689900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanocidal activity of arsonoliposomes: effect of vesicle lipid composition.
    Zagana P; Klepetsanis P; Ioannou PV; Loiseau PM; Antimisiaris SG
    Biomed Pharmacother; 2007 Sep; 61(8):499-504. PubMed ID: 17606357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of PEG-lipids in arsonoliposomes results in formation of highly stable arsenic-containing vesicles.
    Piperoudi S; Fatouros D; Ioannou PV; Frederik P; Antimisiaris SG
    Chem Phys Lipids; 2006 Feb; 139(2):96-106. PubMed ID: 16405880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo distribution of arsenic after i.p. injection of arsonoliposomes in balb-c mice.
    Antimisiaris SG; Klepetsanis P; Zachariou V; Giannopoulou E; Ioannou PV
    Int J Pharm; 2005 Jan; 289(1-2):151-8. PubMed ID: 15652207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of pH on the electrophoretic behaviour of a new class of liposomes: arsonoliposomes.
    Fatouros DG; Klepetsanis P; Ioannou PV; Antimisiaris SG
    Int J Pharm; 2005 Jan; 288(1):151-6. PubMed ID: 15607267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemolytic activity of liposomes: effect of vesicle size, lipid concentration and polyethylene glycol-lipid or arsonolipid incorporation.
    Mourtas S; Michanetzis GP; Missirlis YF; Antimisiaris SG
    J Biomed Nanotechnol; 2009 Aug; 5(4):409-15. PubMed ID: 20055087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transfer by means of lipo- and polyplexes: role of clathrin and caveolae-mediated endocytosis.
    Rejman J; Conese M; Hoekstra D
    J Liposome Res; 2006; 16(3):237-47. PubMed ID: 16952878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Novel Medulloblastoma Cell-Targeting Peptides for Use in Selective Chemotherapy Drug Delivery.
    Tjandra KC; McCarthy N; Yang L; Laos AJ; Sharbeen G; Phillips PA; Forgham H; Sagnella SM; Whan RM; Kavallaris M; Thordarson P; McCarroll JA
    J Med Chem; 2020 Mar; 63(5):2181-2193. PubMed ID: 31347843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study.
    Akhtar A; Wang SX; Ghali L; Bell C; Wen X
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent therapeutic advances for treating medulloblastoma: focus on new molecular targets.
    Schmidt AL; Brunetto AL; Schwartsmann G; Roesler R; Abujamra AL
    CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):335-48. PubMed ID: 20438440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.
    Xie Q; Deng W; Yuan X; Wang H; Ma Z; Wu B; Zhang X
    Eur J Pharm Biopharm; 2018 Jan; 122():87-95. PubMed ID: 29032193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.